Palvella Therapeutics PVLA
NASDAQ PVLA
$123.92 +0.96 (+0.78%)
At close: Oct 20, 2026 · 4:00 PM EDT

Palvella Therapeutics (PVLA) Long-Term Debt Issuances (2024)

Updated

Palvella Therapeutics (PVLA) recorded Long-Term Debt Issuances of $6 million in Q4 2024, up 146.6% from the prior quarter.

Analysis

Palvella Therapeutics (PVLA) Long-Term Debt Issuances (2024) Analysis & Trends

For FY2024, Palvella Therapeutics reported Long-Term Debt Issuances of $18.43 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn -
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -
10 Palvella Therapeutics 1.77 Bn 1.52 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 6.00 Mn
Sep 30, 2024 2.43 Mn
API Access

Palvella Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=PVLA&period=max&api_key=YOUR_API_KEY